Amsterdam Molecular Therapeutics Holding BV, a Dutch gene therapy company, has set its proposed IPO terms to five million common shares being offered at
Amsterdam Molecular Therapeutics Holding BV, a Dutch gene therapy company, has set its proposed IPO terms to five million common shares being offered at
Copyright PEI Media
Not for publication, email or dissemination